Analyst Ratings for Dyne Therapeutics (DYN)
DYN Rating Summary
DYN Price Target Summary
- Highest: $50.00 (Jefferies)
- Lowest: $16.00 (JPMorgan)
- Average: $37.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$37.29 (+48.3%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
Avg. $ Target:
$37.29 (+48.3%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2026 | Cantor Fitzgerald | Eric Schmidt | New Coverage | Overweight (N/A) |
N/A (N/A) |
23.21 (25.14) |
8.32% | Details |
| 6/26/2026 | TD Cowen | Joseph Thome | New Coverage | Buy (N/A) |
N/A (N/A) |
20.61 (25.14) |
21.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
